Kiniksa Pharmaceuticals International, plc KNSA Free cash flow margin
Free cash flow margin at other companies
Other financials
Where this comes from
Calculated from Kiniksa Pharmaceuticals International, plc’s reported figures.
Based on trailing twelve months.
The official record: Kiniksa Pharmaceuticals International, plc’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Kiniksa Pharmaceuticals International, plc's free cash flow margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Kiniksa Pharmaceuticals International, plc's free cash flow margin?
- Kiniksa Pharmaceuticals International, plc (KNSA) reported free cash flow margin of 21.8% in Q1 2026.
- How has Kiniksa Pharmaceuticals International, plc's free cash flow margin changed year-over-year?
- Kiniksa Pharmaceuticals International, plc's free cash flow margin increased by 128.0% year-over-year, from 9.6% to 21.8%.
- What is the long-term trend for Kiniksa Pharmaceuticals International, plc's free cash flow margin?
- Over 3 years (2021 to 2025), Kiniksa Pharmaceuticals International, plc's free cash flow margin has grown at a -60.6% compound annual growth rate (CAGR), from -328.7% to 20.1%.
- What does free cash flow margin mean?
- Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.